Markets:

Overview

News

Currencies

International

Treasuries

Nkarta, Inc. - Common Stock (NQ:NKTX)

3.220 +0.370 (+12.98%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nkarta, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

These Analysts Revise Their Forecasts On Nkarta After Q4 Results ↗

March 22, 2024

Nkarta, Inc. (NASDAQ: NKTX) posted a loss for the fourth quarter on Thursday.

Via Benzinga

NKTX Stock Earnings: Nkarta Beats EPS for Q4 2023 ↗

March 21, 2024

NKTX stock results show that Nkarta beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

3 Overlooked Stocks Ready to Capture the Market by Storm ↗

March 19, 2024

Here are three overlooked stocks ready to revolutionize and gear up for tech consulting, wireless telecommunication and biotechnology.

Via InvestorPlace

3 Silent Tech Titans-in-the-Making: Invest Before They Skyrocket ↗

February 29, 2024

Unlock the potential of tech sector investments with insights on three stocks poised for remarkable growth in diverse industries.

Via InvestorPlace

Last Call! 7 Small-Cap Stocks Ready to Explode in Value ↗

February 20, 2024

Discover the small-cap stocks in the telecommunications, biotech, research, silver, transportation, and trading, ready to explode in value.

Via InvestorPlace

3 Under-the-Radar Stocks Set to Soar 300% by 2026 ↗

February 08, 2024

Uncover the potential of three under-the-radar stocks for 300% growth by 2026, spanning tech, biotech and energy sectors.

Via InvestorPlace

Analyst Ratings for Nkarta ↗

December 12, 2023

Via Benzinga

The Latest Analyst Ratings for Nkarta ↗

November 16, 2023

Via Benzinga

Analyst Expectations for Nkarta's Future ↗

October 18, 2023

Via Benzinga

3 Sleeper Stocks With Serious Potential to Make You a Millionaire ↗

February 06, 2024

Investors might miss these under-the-radar stocks and miss out on gains. Here are three sleeper companies with millionaire potential.

Via InvestorPlace

3 Once-in-a-Lifetime Biotech Stocks With Unprecedented Surge Potential ↗

February 05, 2024

As the new business cycle gets started, here are some biotech stocks with potential that investors should pay attention to.

Via InvestorPlace

Unseen Giants: 3 Stocks Quietly Preparing for a 10X Surge ↗

February 04, 2024

These companies, spanning the semiconductor, healthcare and biotechnology sectors, are emerging as unseen giants with the potential for a 10X surge.

Via InvestorPlace

Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

January 09, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:AMGN),(NASDAQ:AMAM),(NASDAQ:ELEV),(NASDAQ:NKTX) EQNX::TICKER_END

Via FinancialNewsMedia

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 19, 2024

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode...

Via Benzinga

Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

January 09, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) shares fell sharply in pre-market...

Via Benzinga

Topics Stocks

Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

January 09, 2024

From FN Media Group LLC

Via GlobeNewswire

What's Going On With Cancer Drug-Developer Nkarta Stock? ↗

January 08, 2024

Nkarta, Inc. (NASDAQ: NKTX) shares are blasting higher Monday, and the stock has gained more than 270% over the past month. Here's a look at what's going on.

Via Benzinga

Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results ↗

January 08, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.35% to 37,596.43 while the NASDAQ rose 1.89% to 14,799.21. The...

Via Benzinga

Topics Stocks

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 08, 2024

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 08, 2024

Via Benzinga

Pinstripes, SoFi Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

January 03, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 60 points on Wednesday. Shares of Pinstripes (NYSE: PNST) shares fell in pre-market trading after surging 22% on...

Via Benzinga

Topics Stocks

Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition

December 09, 2023

From Nkarta, Inc.

Via GlobeNewswire

Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights

November 09, 2023

From Nkarta, Inc.

Via GlobeNewswire

These Biotech Stocks Could Double Your Money, According To Analysts ↗

November 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 19, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023 ↗

October 18, 2023

Via Benzinga

Visa To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

October 18, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 17, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 17, 2023

Via Benzinga

What's Going With Cancer-Focused Nkarta Stock Today? ↗

October 17, 2023

Nkarta Inc (NASDAQ: NKTX) received FDA clearance for its Investigational New Drug (IND) application to evaluate NKX019, its allogeneic, CD19-directed CAR NK cell therapy candidate,

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.